AU2003234976A1 - The use of the human urinary kininogenase in the manufacture of a medicine for treating and preventing cerebral embolism - Google Patents

The use of the human urinary kininogenase in the manufacture of a medicine for treating and preventing cerebral embolism

Info

Publication number
AU2003234976A1
AU2003234976A1 AU2003234976A AU2003234976A AU2003234976A1 AU 2003234976 A1 AU2003234976 A1 AU 2003234976A1 AU 2003234976 A AU2003234976 A AU 2003234976A AU 2003234976 A AU2003234976 A AU 2003234976A AU 2003234976 A1 AU2003234976 A1 AU 2003234976A1
Authority
AU
Australia
Prior art keywords
medicine
treating
manufacture
cerebral embolism
human urinary
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003234976A
Inventor
Heliang Fu
Xiaoyan Wang
Jindi Wu
Yongli Xie
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Guangdong Techpool Bio Pharma Co Ltd
Original Assignee
Guangdong Techpool Bio Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Guangdong Techpool Bio Pharma Co Ltd filed Critical Guangdong Techpool Bio Pharma Co Ltd
Publication of AU2003234976A1 publication Critical patent/AU2003234976A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/4853—Kallikrein (3.4.21.34 or 3.4.21.35)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
AU2003234976A 2002-05-13 2003-05-12 The use of the human urinary kininogenase in the manufacture of a medicine for treating and preventing cerebral embolism Abandoned AU2003234976A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CNB021167834A CN1183966C (en) 2002-05-13 2002-05-13 Application of human urokininogenase in preparing medicine for preventing and treating cerebral infraction
CN02116783.4 2002-05-13
PCT/CN2003/000345 WO2003094935A1 (en) 2002-05-13 2003-05-12 The use of the human urinary kininogenase in the manufacture of a medicine for treating and preventing cerebral embolism

Publications (1)

Publication Number Publication Date
AU2003234976A1 true AU2003234976A1 (en) 2003-11-11

Family

ID=4744233

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003234976A Abandoned AU2003234976A1 (en) 2002-05-13 2003-05-12 The use of the human urinary kininogenase in the manufacture of a medicine for treating and preventing cerebral embolism

Country Status (3)

Country Link
CN (1) CN1183966C (en)
AU (1) AU2003234976A1 (en)
WO (1) WO2003094935A1 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1308035C (en) * 2004-11-03 2007-04-04 广东天普生化医药股份有限公司 Application of human urine kininogenase for preparing medicine to treat acute coronary syndromes
CN1292793C (en) * 2004-11-03 2007-01-03 广东天普生化医药股份有限公司 Application of kininogenase of human urine in preparing medication for treating pyemia
CN1318090C (en) * 2004-11-29 2007-05-30 广东天普生化医药股份有限公司 Medicine composition for improving stability of human urine kininogenase
CN100388950C (en) * 2006-09-05 2008-05-21 广东天普生化医药股份有限公司 Application of human urokinase-type peptidase in preparing medicine for treating diabetes combined cerebral infraction
CN101134953B (en) * 2007-07-02 2011-02-09 广东天普生化医药股份有限公司 Recombinant human pancreas kininogenase
CN101134106B (en) * 2007-07-02 2012-01-11 广东天普生化医药股份有限公司 Pharmaceutical composition containing human urine kininogenase for treating cerebral infarction
CN101134105B (en) * 2007-07-02 2011-04-20 广东天普生化医药股份有限公司 Pharmaceutical composition containing recombination human pancreatic kininogenase for treating and/or preventing cerebral infarction
WO2009039704A1 (en) * 2007-09-27 2009-04-02 Shanghai Wanxing Biopharmaceuticals, Co., Ltd. A method for producing human kallikrein 1
CN101879310A (en) * 2010-06-13 2010-11-10 广东天普生化医药股份有限公司 Application of human urinary kallidinogenase in preparing medicine for treating diabetic nephropathy
CN101879308B (en) * 2010-06-13 2012-04-18 广东天普生化医药股份有限公司 Application of human urinary kallidinogenase in preparing medicine for treating acute renal failureacute renal failure
CN101879309A (en) * 2010-06-13 2010-11-10 广东天普生化医药股份有限公司 Application of human urinary kallidinogenase in preparing medicine for treating diabetic foot ulcers
CN108969758B (en) * 2018-09-07 2020-03-24 广东天普生化医药股份有限公司 Application of human urinary kallidinogenase in preparing medicine for treating thromboangiitis obliterans

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0546533A2 (en) * 1991-12-10 1993-06-16 Sanwa Kagaku Kenkyusho Co., Ltd. Medical use of kininogenase

Also Published As

Publication number Publication date
CN1403156A (en) 2003-03-19
CN1183966C (en) 2005-01-12
WO2003094935A1 (en) 2003-11-20

Similar Documents

Publication Publication Date Title
HK1089376A1 (en) Formulation for use in the prevention and treatment of carbohydrate induced ; diseases and conditions
EP1455778A4 (en) Methods for the treatment of peripheral neural and vascular ailments
AU2003264282A1 (en) Phenethanolamine derivatives and their use in the treatment of respiratory diseases
AU2003300200A1 (en) Valve treatment catheter and methods
AU2003290548A1 (en) Prevention and treatment of synucleinopathic disease
AU2003243551A1 (en) Use of an anti-endotoxin drug in the prevention and treatment of disease
IL164211A0 (en) Il-18 inhibitors and peripheral vascular diseases
AU2003278775A8 (en) Porifera-based therapeutic compositions for treating and preventing skin diseases
AU2002339128A1 (en) Use of reelin, gas6, and protein s in the treatment of neural disorders
AU2003202075A1 (en) Modulator of the notch signalling pathway and use thereof in medical treatment
AU2003234976A1 (en) The use of the human urinary kininogenase in the manufacture of a medicine for treating and preventing cerebral embolism
IL166363A0 (en) 1-phenyl-2-dimethylaminomethyl cyclohexane compounds used for the therapy of depressive symptoms pa in and incontinence
AU2003286285A1 (en) Use of fgf-18 in the diagnosis and treatment of memory disorders
EP1679070A4 (en) Use of l-butylphthalide in the manufacture of medicaments for prevention and treatment of cerebral infarct
PL371281A1 (en) Methods and compositions for the treatment of eye diseases
AU2003232148A1 (en) A selective inos inhibitor and a pde inhibitor in combination for the treatment of respiratory diseases
EP1514551A4 (en) Antiinflammatory agent, agent for preventing/ameliorating allergic diseases and functional food
AU2003238242A1 (en) Use of an anti-endotoxin drug in the prevention and treatment of disease
GB2383537B (en) Use of a compound in providing refreshedness on waking and a method for the treatment of drowsiness therewith
AU2002313364A1 (en) Use of a compound in providing refreshedness on waking and a method for the treatment of drowsiness therewith
IL162941A0 (en) Carboxamidine derivatives and their use in the treatment of vascular diseases
AU2003244455A1 (en) Piperidylcarboxamide derivatives and their use in the treatment of tachykinim-mediated diseases
AU2003213898A1 (en) Prevention and treatment of mycoplasma-associated diseases
AU2003211258A1 (en) Stent for intracranial vascular therapy and process for producing the same
IL162776A0 (en) 2'-Halo-3',5'-dialkoxyphen-1'-yl-imino-2-imidazolidine derivatives and the use thereof for the treatment of urinary incontinence

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase
TH Corrigenda

Free format text: IN VOL 18, NO 2, PAGE(S) 591 UNDER THE HEADING APPLICATIONS OPI - NAME INDEX UNDER THE NAME TECHPOOL BIO-PHARMA CO., LTD., APPLICATION NO. 2003234976, UNDER INID (43) CORRECT THE PUBLICATION DATE TO READ 24.11.2003